BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6197332)

  • 21. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
    Menozzi D; Gardner JD; Jensen RT; Maton PN
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new CCK analogue differentiates two functionally distinct CCK receptors in rat and mouse pancreatic acini.
    Matozaki T; Martinez J; Williams JA
    Am J Physiol; 1989 Oct; 257(4 Pt 1):G594-600. PubMed ID: 2478032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of a cholecystokinin analogue with partial agonist activity.
    Howard JM; Knight M; Jensen RT; Gardner JD
    Am J Physiol; 1984 Sep; 247(3 Pt 1):G261-4. PubMed ID: 6206732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of proglumide on rat pancreatic growth.
    Yamaguchi T; Tabata K; Johnson LR
    Am J Physiol; 1985 Aug; 249(2 Pt 1):G294-8. PubMed ID: 2411150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of gastrin receptors on guinea pig pancreatic acini.
    Yu DH; Noguchi M; Zhou ZC; Villanueva ML; Gardner JD; Jensen RT
    Am J Physiol; 1987 Dec; 253(6 Pt 1):G793-801. PubMed ID: 2447788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog.
    Fried M; Beglinger C; Koehler E; Whitehouse I; Varga L; Gyr K
    Regul Pept; 1984 Mar; 8(2):117-22. PubMed ID: 6729149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Derivatives of CCK-(26-32) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
    Gardner JD; Knight M; Sutliff VE; Tamminga CA; Jensen RT
    Am J Physiol; 1984 Mar; 246(3 Pt 1):G292-5. PubMed ID: 6199984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of cholecystokinin in pancreatic exocrine response to intraluminal amino acids and fat.
    Stubbs RS; Stabile BE
    Am J Physiol; 1985 Mar; 248(3 Pt 1):G347-52. PubMed ID: 2858160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of porcine gastrin-releasing peptide on amylase release, 2-deoxyglucose uptake, and alpha-aminoisobutyric acid uptake in mouse pancreatic acini.
    Iwamoto Y; Nakamura R; Akanuma Y
    Endocrinology; 1983 Dec; 113(6):2106-12. PubMed ID: 6196181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholecystokinin receptors on gallbladder muscle and pancreatic acinar cells: a comparative study.
    von Schrenck T; Moran TH; Heinz-Erian P; Gardner JD; Jensen RT
    Am J Physiol; 1988 Oct; 255(4 Pt 1):G512-21. PubMed ID: 3177648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feeding behavior response of Zucker rats to proglumide, a CCK receptor antagonist.
    McLaughlin CL; Peikin SR; Baile CA
    Pharmacol Biochem Behav; 1983 Jun; 18(6):879-83. PubMed ID: 6310643
    [No Abstract]   [Full Text] [Related]  

  • 33. The anti-CCK effect of glutaramic acid derivatives in anesthetized and conscious rats.
    Takács T; Nagy I; Pap A; Varró V
    Pancreas; 1988; 3(4):465-70. PubMed ID: 3174609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic receptors for cholecystokinin: evidence for three receptor classes.
    Yu DH; Huang SC; Wank SA; Mantey S; Gardner JD; Jensen RT
    Am J Physiol; 1990 Jan; 258(1 Pt 1):G86-95. PubMed ID: 2301586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of cholecystokinin in canine pancreatic exocrine response to bombesin stimulation.
    Nealon WH; Beauchamp RD; Townsend CM; Thompson JC
    Am J Surg; 1987 Jan; 153(1):96-101. PubMed ID: 3799899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proglumide inhibition of trophic action of pentagastrin.
    Johnson LR; Guthrie PD
    Am J Physiol; 1984 Jan; 246(1 Pt 1):G62-6. PubMed ID: 6320664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that proglumide and benzotript antagonize secretagogue stimulation of isolated gastric parietal cells.
    Magous R; Bali JP
    Regul Pept; 1983 Nov; 7(3):233-41. PubMed ID: 6320314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proglumide, a cholecystokinin antagonist, increases gastric emptying in rats.
    Shillabeer G; Davison JS
    Am J Physiol; 1987 Feb; 252(2 Pt 2):R353-60. PubMed ID: 3812772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proglumide inhibits cholecystokinin and meal-stimulated pancreatic secretion and release of pancreatic polypeptide.
    Beauchamp RD; Gomez G; Nealon WH; Townsend CM; Greeley GH; Thompson JC
    Surgery; 1990 Sep; 108(3):553-8. PubMed ID: 2396199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists.
    Makovec F; Bani M; Cereda R; Chisté R; Pacini MA; Revel L; Rovati LA; Rovati LC; Setnikar I
    Arzneimittelforschung; 1987 Nov; 37(11):1265-8. PubMed ID: 3440035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.